novel treatments

Research in Review

Hypomethylating Agents Improve Survival in Older Patients With CMML

06/19/2017

JCP Editors

Older patients with chronic myelomonocytic leukemia (CMML) who are treated with hypomethylating agents reduce their risk of disease-related mortality by 28%, according to new research published in Cancer (published...

Older...

06/19/2017

Journal of Clinical Pathways

Research in Review

High Response Rates With New Treatment for Aggressive B-Cell Lymphoma

06/13/2017

JCP Editors

In a recent trial, researchers determined complete response rates in patients with aggressive B-cell lymphomas after treatment with new a CAR T-cell product. ----- Related Content B-Cell ALL Disease Burden May...

In a...

06/13/2017

Journal of Clinical Pathways

Research in Review

CAR T-Cells May Have Therapeutic Value in Solid Cancers

06/07/2017

JCP Editors

Chimeric antigen receptor (CAR) T-cells may elicit responses in solid cancers by inducing cancer cell death and the release of tumor antigens that could stimulate T-cell activity, according to research presented at...

...

06/07/2017

Journal of Clinical Pathways

Gemcitabine-Based Chemoradiation Effective Bladder Cancer Treatment for Underdeveloped Nations

06/04/2017

JCP Editors

Neoadjuvant gemcitabine-based chemotherapy, followed by gemcitabine-based concomitant chemoradiation, may aid in bladder preservation for patients receiving treatment for muscle-invasive bladder cancer in...

...

06/04/2017

Journal of Clinical Pathways

Research in Review

Novel Therapy Induces High Response Rate in Metastatic NSCLC

06/01/2017

JCP Editors

A novel antibody-drug conjugate is well tolerated and induces durable responses in pretreated patients with advanced non-small cell lung cancer (NSCLC), according to research published in the Journal of Clinical...

A...

06/01/2017

Journal of Clinical Pathways

Research in Review

Dose-Escalated Therapy May Be Curative for Multiple B-Cell Malignancies

04/26/2017

JCP Editors

Dose-escalated therapy involving a single agent produced complete and partial responses in patients with different B-cell malignancies. ----- Related Content Maintenance Therapy Effective in Treating Diffuse Large...

...

04/26/2017

Journal of Clinical Pathways

Research in Review

Maintenance Therapy After Autologous Stem Cell Transplant Improves Survival in MCL

04/18/2017

JCP Editors

Younger patients with mantle cell lymphoma (MCL) who receive an autologous hematopoietic cell transplant after an induction regimen are more likely to prolong their survival with maintenance therapy. ----- Related...

...

04/18/2017

Journal of Clinical Pathways

Research in Review

Maintenance Therapy Effective in Treating Diffuse Large B-Cell Lymphoma

04/12/2017

JCP Editors

Maintenance therapy with a targeting agent may provide survival benefits beyond first- and second-line chemotherapy in patients with diffuse large B-cell lymphoma, according to an analysis published in PLOS One...

...

04/12/2017

Journal of Clinical Pathways

Research in Review

Combined Treatment Approach Improves Survival for Patients With Glioblastoma

04/03/2017

JCP Editors

A combination therapy for patients with newly diagnosed glioblastoma maintains improvement in overall survival (OS) after 5 years, according to recently published results of a phase III trial. ----- Related...

A...

04/03/2017

Journal of Clinical Pathways

Research in Review

Meta-Analysis Reveals Optimal Combination Therapy for Multiple Myeloma

03/24/2017

JCP Editors

A triple-combination treatment strategy is the most effective therapy for patients with relapsed or refractory multiple myeloma, according to a meta-analysis published in the Journal of Clinical Oncology (published...

A...

03/24/2017

Journal of Clinical Pathways